Study on SuJok Therapy for Primary Dysmenorrhea Shows Potential Benefits
A clinical trial is investigating the effects of SuJok therapy on dysmenorrhea and quality of life in young women.
Phase III
Gynecology / Dysmenorrhea
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing clinical trial on SuJok therapy for primary dysmenorrhea could introduce a non-pharmacological treatment option, potentially reshaping the landscape of pain management solutions. Pharma companies must stay informed about the trial's outcomes to assess the implications for their product portfolios and competitive positioning.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the trial results and any subsequent publications that validate the efficacy of SuJok therapy in treating dysmenorrhea.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.